MedTrace Logo

Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA)

NCT00852059 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2014-05-07

No results posted yet for this study

Summary

This study determined to measure non-adherence assessed by the number of non-adherent days during the clinical trial of 100 days using the Medication Event Monitoring System (MEMS).

Study Design:

* prospective
* multi-centric
* open-label
* randomized
* active-controlled trial

Conditions

  • ADHD

Interventions

DRUG

Immediate release methylphenidate (Medikinet®)

Treatment: methylphenidate in the morning and 3-4 h later (twice daily), immediate release

DRUG

Extended release methylphenidate (Medikinet retard®)

Treatment: methylphenidate applied with breakfast(once daily), extended release

Sponsors & Collaborators

  • Prof. Huss

    lead OTHER

Principal Investigators

  • Michael Huss, Prof. Dr. · Johannes Gutenberg University, Mainz, Dep. of Child and Adolescent Psychiatry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00852059 on ClinicalTrials.gov